374 related articles for article (PubMed ID: 31948289)
1. Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system.
Onyszkiewicz M; Jaworska K; Ufnal M
Exp Biol Med (Maywood); 2020 Jan; 245(2):166-175. PubMed ID: 31948289
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO.
Poll BG; Cheema MU; Pluznick JL
Physiology (Bethesda); 2020 Jul; 35(4):275-284. PubMed ID: 32490748
[TBL] [Abstract][Full Text] [Related]
3. Interaction between gut microbiome and cardiovascular disease.
Peng J; Xiao X; Hu M; Zhang X
Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous HS-SPME GC-MS determination of short chain fatty acids, trimethylamine and trimethylamine N-oxide for gut microbiota metabolic profile.
Fiori J; Turroni S; Candela M; Brigidi P; Gotti R
Talanta; 2018 Nov; 189():573-578. PubMed ID: 30086962
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
[TBL] [Abstract][Full Text] [Related]
6. Targeting on Gut Microbial Metabolite Trimethylamine-N-Oxide and Short-Chain Fatty Acid to Prevent Maternal High-Fructose-Diet-Induced Developmental Programming of Hypertension in Adult Male Offspring.
Hsu CN; Chang-Chien GP; Lin S; Hou CY; Tain YL
Mol Nutr Food Res; 2019 Sep; 63(18):e1900073. PubMed ID: 31295767
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and microbiota-derived metabolites in cardiovascular diseases.
Chen X; Zhang H; Ren S; Ding Y; Remex NS; Bhuiyan MS; Qu J; Tang X
Chin Med J (Engl); 2023 Oct; 136(19):2269-2284. PubMed ID: 37442759
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
9. Microbiome metabolite quantification methods enabling insights into human health and disease.
Roach J; Mital R; Haffner JJ; Colwell N; Coats R; Palacios HM; Liu Z; Godinho JLP; Ness M; Peramuna T; McCall LI
Methods; 2024 Feb; 222():81-99. PubMed ID: 38185226
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
Agus A; Clément K; Sokol H
Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
[TBL] [Abstract][Full Text] [Related]
11. A cross-talk between gut microbiome, salt and hypertension.
Naqvi S; Asar TO; Kumar V; Al-Abbasi FA; Alhayyani S; Kamal MA; Anwar F
Biomed Pharmacother; 2021 Feb; 134():111156. PubMed ID: 33401080
[TBL] [Abstract][Full Text] [Related]
12. Soluble Dietary Fiber Reduces Trimethylamine Metabolism via Gut Microbiota and Co-Regulates Host AMPK Pathways.
Li Q; Wu T; Liu R; Zhang M; Wang R
Mol Nutr Food Res; 2017 Dec; 61(12):. PubMed ID: 28884952
[TBL] [Abstract][Full Text] [Related]
13. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.
Hoyles L; Jiménez-Pranteda ML; Chilloux J; Brial F; Myridakis A; Aranias T; Magnan C; Gibson GR; Sanderson JD; Nicholson JK; Gauguier D; McCartney AL; Dumas ME
Microbiome; 2018 Apr; 6(1):73. PubMed ID: 29678198
[TBL] [Abstract][Full Text] [Related]
14. Implication of Gut Microbiota in Cardiovascular Diseases.
Zhou W; Cheng Y; Zhu P; Nasser MI; Zhang X; Zhao M
Oxid Med Cell Longev; 2020; 2020():5394096. PubMed ID: 33062141
[TBL] [Abstract][Full Text] [Related]
15. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
[TBL] [Abstract][Full Text] [Related]
16. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.
Morrison DJ; Preston T
Gut Microbes; 2016 May; 7(3):189-200. PubMed ID: 26963409
[TBL] [Abstract][Full Text] [Related]
17. Applying mass spectrometry-based assays to explore gut microbial metabolism and associations with disease.
Heaney LM
Clin Chem Lab Med; 2020 Apr; 58(5):719-732. PubMed ID: 31639103
[TBL] [Abstract][Full Text] [Related]
18. Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.
Duttaroy AK
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33401598
[TBL] [Abstract][Full Text] [Related]
19. Dietary Patterns Affect the Gut Microbiome-The Link to Risk of Cardiometabolic Diseases.
Tindall AM; Petersen KS; Kris-Etherton PM
J Nutr; 2018 Sep; 148(9):1402-1407. PubMed ID: 30184227
[TBL] [Abstract][Full Text] [Related]
20. Understanding connections and roles of gut microbiome in cardiovascular diseases.
Rajendiran E; Ramadass B; Ramprasath V
Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
